Albert David Limited has informed the Exchange that Record date for the purpose of Dividend & 86th Annual General Meeting is 25-Jul-2025.
ALBERTDAVD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.9 pts less than Nifty Microcap 250 and 7.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Albert David Limited's Board met on May 13, 2025 and approved audited results for Q4 and FY ended March 31, 2025 with an unmodified audit opinion from L. B. Jha & Co. Revenue from operations for FY25 fell to Rs. 34,576.80 lakhs from Rs. 36,246.17 lakhs in FY24, a decline of about 4.6%. Profit after tax dropped sharply to Rs. 1,720.08 lakhs from Rs. 7,542.01 lakhs, with full-year EPS of Rs. 30.14 versus Rs. 132.15 last year. The Q4 standalone numbers swung to a loss of Rs. 1,032.79 lakhs versus a profit of Rs. 1,291.26 lakhs in the year-ago quarter. The Board recommended a final dividend of Rs. 5.00 per share (50%) and fixed July 25, 2025 as the record date, with the 86th AGM on August 2, 2025. PricewaterhouseCoopers was reappointed as Internal Auditor, S. Gupta & Co. as Cost Auditor, and MKB & Associates was appointed as Secretarial Auditor for five years.
Sharp profit decline, margin compression and a Q4 loss are likely to weigh on the stock in the short term, even though a 50% dividend provides some income support. The negative operating cash flow and weakening Q4 may raise concerns about near-term earnings momentum.